Compare SHRI CHLOCHEM with HK FINECHEM - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ARCHIT ORGANOSYS vs PRIVI SPECIALITY CHEMICALS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ARCHIT ORGANOSYS PRIVI SPECIALITY CHEMICALS ARCHIT ORGANOSYS/
PRIVI SPECIALITY CHEMICALS
 
P/E (TTM) x 9.4 59.4 15.9% View Chart
P/BV x 2.0 10.3 19.1% View Chart
Dividend Yield % 0.0 0.1 -  

Financials

 ARCHIT ORGANOSYS   PRIVI SPECIALITY CHEMICALS
EQUITY SHARE DATA
    ARCHIT ORGANOSYS
Mar-20
PRIVI SPECIALITY CHEMICALS
Mar-21
ARCHIT ORGANOSYS/
PRIVI SPECIALITY CHEMICALS
5-Yr Chart
Click to enlarge
High Rs15937 1.6%   
Low Rs6308 1.9%   
Sales per share (Unadj.) Rs51.1326.8 15.6%  
Earnings per share (Unadj.) Rs-0.529.9 -1.8%  
Cash flow per share (Unadj.) Rs1.848.1 3.7%  
Dividends per share (Unadj.) Rs02.00 0.0%  
Avg Dividend yield %00.3 0.0%  
Book value per share (Unadj.) Rs22.7185.0 12.3%  
Shares outstanding (eoy) m15.0239.06 38.5%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.21.9 10.5%   
Avg P/E ratio x-19.220.8 -92.1%  
P/CF ratio (eoy) x5.712.9 44.4%  
Price / Book Value ratio x0.53.4 13.4%  
Dividend payout %06.7 0.0%   
Avg Mkt Cap Rs m15424,319 0.6%   
No. of employees `000NANA-   
Total wages/salary Rs m62699 8.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m76712,766 6.0%  
Other income Rs m23200 11.5%   
Total revenues Rs m79012,965 6.1%   
Gross profit Rs m362,329 1.5%  
Depreciation Rs m35710 4.9%   
Interest Rs m32237 13.4%   
Profit before tax Rs m-81,582 -0.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m0413 0.0%   
Profit after tax Rs m-81,169 -0.7%  
Gross profit margin %4.718.2 25.5%  
Effective tax rate %-1.326.1 -4.8%   
Net profit margin %-1.09.2 -11.4%  
BALANCE SHEET DATA
Current assets Rs m3047,002 4.3%   
Current liabilities Rs m3574,536 7.9%   
Net working cap to sales %-6.919.3 -35.8%  
Current ratio x0.91.5 55.1%  
Inventory Days Days419 18.8%  
Debtors Days Days94683 13.7%  
Net fixed assets Rs m5238,401 6.2%   
Share capital Rs m150391 38.5%   
"Free" reserves Rs m1916,835 2.8%   
Net worth Rs m3417,225 4.7%   
Long term debt Rs m1243,318 3.7%   
Total assets Rs m82615,402 5.4%  
Interest coverage x0.87.7 9.8%   
Debt to equity ratio x0.40.5 79.1%  
Sales to assets ratio x0.90.8 112.0%   
Return on assets %2.99.1 31.5%  
Return on equity %-2.316.2 -14.5%  
Return on capital %5.117.3 29.7%  
Exports to sales %077.9 0.0%   
Imports to sales %042.8 0.0%   
Exports (fob) Rs mNA9,947 0.0%   
Imports (cif) Rs mNA5,465 0.0%   
Fx inflow Rs m09,947 0.0%   
Fx outflow Rs m05,465 0.0%   
Net fx Rs m04,482 0.0%   
CASH FLOW
From Operations Rs m781,721 4.5%  
From Investments Rs m-9-2,415 0.4%  
From Financial Activity Rs m-892 -5,721.9%  
Net Cashflow Rs m-20-693 2.8%  

Share Holding

Indian Promoters % 57.4 25.3 226.9%  
Foreign collaborators % 0.0 48.8 -  
Indian inst/Mut Fund % 0.0 1.6 -  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 42.6 25.9 164.2%  
Shareholders   7,636 11,938 64.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ARCHIT ORGANOSYS With:   CHEMFAB ALKALIS  ARVEE LABS  SUNIL HEALTHCARE  DCW.  RESONANCE SPEC.  



Today's Market

Sensex Slumps 700 Points from Day's High to End Lower; Tata Steel & SBI Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

Shares of Oxygen Suppliers in Focus Amid Rising Demand for Oxygen (Company Info)

Apr 20, 2021

In this article, we discuss the hype around Oxygen supplier stocks and a little known NBFC company, which has rallied 150% in less than a month.

Nazara Technologies IPO: Should You Apply? (IPO)

Mar 17, 2021

Should you bet on this gaming company backed by ace investor Rakesh Jhunjhunwala?

More Views on News

Most Popular

Sansera Engineering IPO: Key Points to Consider(Views On News)

Sep 8, 2021

This IPO is a pure OFS and the company is looking to raise Rs 12.8 bn at the upper price band of Rs 744.

5 Stocks that Turned Rs 1 Lakh into Rs 1 Crore(Views On News)

Sep 7, 2021

Patience is one of the biggest virtues you need to have if you want to become a crorepati in the stock market.

The Top Stocks to Sell in this Bull Market(Profit Hunter)

Sep 8, 2021

When I saw the list of so-called 'value stocks' published by a leading brokerage, my worst fears came true.

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ARCHIT ORGANOSYS SHARE PRICE


Sep 17, 2021 (Close)

TRACK ARCHIT ORGANOSYS

  • Track your investment in ARCHIT ORGANOSYS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ARCHIT ORGANOSYS

ARCHIT ORGANOSYS 5-YR ANALYSIS

COMPARE ARCHIT ORGANOSYS WITH

MARKET STATS